Sagot, Jimiliz .
HRN: 21-77-64 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2022
CO-AMOXICLAV 625MG (TAB)
09/28/2022
10/04/2022
PO
625mg
BID
RMLE Repair
Waiting Final Action